Covid19, Type 1 Diabetes
Conditions
Keywords
Type 1 Diabetes, Covid 19, Diabetic ketoacidosis
Brief summary
Although reports showed that children with well controlled diabetes do not appear to have increased risk of infection with SARS-CoV-2, however data are scarce regarding the extent to which clinical and demographic data of patient could modify the outcome and severity of the disease. Additionally, the link between covid-19 and diabetes remains controversial.
Detailed description
Data from poorly controlled patients with type 1 diabetes remains controversial regarding whether diabetes itself could increases the susceptibility of infection with SARS-CoV-2 and subsequently impacts the outcomes in these patients , or the SARS-CoV-2 subsequently affects the risk of type 1 diabetes and increase in the prevalence of severe DKA. Poorly controlled diabetes and chronic hyperglycemia creates a state of low grade chronic inflammation, which may explain the underlying mechanism of increased susceptibility to infection and infer the outcome in patients with diabetes . Poorly controlled diabetes has been linked to multiple derangements of immune system including inhibition of lymphocyte proliferation in response to different stimuli, as well as impaired monocyte/macrophage function together with increased synthesis of pro-inflammatory cytokines and adhesion molecules that mediate tissue inflammation . Few data links the association between development of diabetic ketoacidosis in patients with COVID-19, where the infection could trigger higher stressful conditions, with the release of stress hormones leading to increased blood glucose levels and abnormal glucose variability . The extent to which clinical and demographic data of patients with type 1 diabetes modifies the outcome and severity of the disease seems entirely unclear and is the question of several researches. • Study Tools: All patients admitted to Pediatrics Hospital, Ain Shams University in the period between May to August 2020 will be subjected to: 1- Detailed history 2. Thorough clinical examination: To assess the inclusion and exclusion criteria. A thorough clinical review to assess organ involvements and clinical and laboratory characteristics as well as the outcome measures in the studied cohort. 3\. Data collection: Demographic and data will be extracted from patients inpatient files and reports
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* All patients with type 1 diabetes admitted to Pediatrics Hospital, Ain Shams University in the period between May to July 2020. * Age: less than 18 years old.
Exclusion criteria
• Children with other forms of diabetes, including: type 2, monogenic forms and secondary diabetes
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Clinical characteristic of pediatric and adolescent patients with type 1 diabetes hospitalized with COVID -19. | 4 months | complications and comorbidities associated with diabetes |
| Laboratory characteristic of pediatric and adolescent patients with type 1 diabetes hospitalized with COVID -19. | 4 months | Acute phase reactants |
| Prognosis of pediatric and adolescent patients with type 1 diabetes hospitalized with COVID -19. | 4 month | Intensive care admission |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of new onset type 1 diabetes among confirmed cases of Covid-19 infection among children and adolescents | 4 months | Incidence of new onset type 1 diabetes among confirmed cases of Covid-19 infection among children and adolescents |
| Presentation of diabetes and its acute complications among pediatric and adolescent patients with type 1 diabetes during COVID-19 Pandemic in Egypt | 4 month | Impact of Covid-19 pandemic on presentation of diabetes and its acute complications among pediatric and adolescent patients with type 1 diabetes |
Countries
Egypt